Humanigen Inc

:HGEND   3:05:57 PM EDT
-1.00 (-5.26%)
Products, Strategic Combinations

Humanigen And Lonza Announce Expanded Collaboration On COVID-19 Candidate

Published: 09/15/2020 05:13 GMT
(HGEND) - Humanigen and Lonza Announce Collaboration to Expand Manufacturing of Humanigen's Covid-19 Therapeutic Candidate Lenzilumab.
Collaboration to Expand Lenzilumab Manufacturing Capacity in Advance of Potential Emergency Use Authorization in 2020.commercial Manufacturing to Begin in 2021 at Lonza's Manufacturing Facility at Hayward.
Collaboration is Projected to Take Lenzilumab Through Product Launch and Commercial Supply.